| Scorecard |
|---|
|
5 / 5 Stars
|
|
Lipper
5
5
3
5
1
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
A+
(Buy)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 28.65 | 18.53 | 10.12 |
| Stocks | 31.58 | 0.0 | 31.58 |
| Bonds | 2.41 | 0.0 | 2.41 |
| Other | 8.55 | 0.81 | 7.74 |
| Foreign Bonds | 5.16 | 1.0 | 4.16 |
| Foreign Stocks | 46.54 | 2.57 | 43.97 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.02 | 0.0 | 0.02 |
Updated 02.28.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 02.28.2013
| % Net Assets | |
|---|---|
| GMO US Flexible Equities VI | 33.95 |
| GMO Intl Intrinsic Value IV | 23.44 |
| GMO International Growth Equity IV | 8.03 |
| GMO Currency Hedged Intl Equity III | 6.57 |
| GMO Strategic Fixed Income VI | 5.27 |
| GMO Flexible Equities VI | 3.92 |
| Gmo Tr | 3.62 |
| GMO Risk Premium VI | 3.49 |
| Gmo Tr | 2.91 |
| GMO Alpha Only IV | 2.89 |
